Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by CASI Pharmaceuticals, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
CASI Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00658671
First received: April 11, 2008
Last updated: June 21, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2012
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by CASI Pharmaceuticals, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):